Nomura Holdings’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.19M Sell
30,942
-120
-0.4% -$38.8K 0.02% 445
2025
Q4
$9.44M Sell
31,062
-5,938
-16% -$1.94M 0.01% 537
2025
Q3
$12.6M Buy
+37,000
New +$11.2M 0.02% 451
2023
Q2
Sell
-1,000
Closed -$216K 1687
2023
Q1
$216K Buy
+1,000
New +$240K ﹤0.01% 1224
2022
Q4
Sell
-2,620
Closed -$353K 1763
2022
Q3
$353K Sell
2,620
-4,000
-60% -$687K ﹤0.01% 1163
2022
Q2
$1.07M Buy
6,620
+1,300
+24% +$203K ﹤0.01% 942
2022
Q1
$1.1M Sell
5,320
-15,798
-75% -$3.36M ﹤0.01% 1074
2021
Q4
$5.72M Buy
21,118
+15,298
+263% +$5.17M 0.01% 654
2021
Q3
$2.1M Hold
5,820
0.01% 902
2021
Q2
$2.08M Sell
5,820
-200
-3% -$66.2K 0.01% 848
2021
Q1
$2M Sell
6,020
-1,180
-16% -$391K ﹤0.01% 864
2020
Q4
$1.84M Buy
+7,200
New +$1.98M ﹤0.01% 876
2018
Q1
Sell
-3,600
Closed -$352K 1723
2017
Q4
$352K Buy
+3,600
New +$330K ﹤0.01% 1379

Other funds holding ONC

Nomura Holdings's ONC Position: Q1 2026 in Review

Nomura Holdings reduced its BeOne Medicines Ltd (ONC) stake by 0.39% in Q1 2026, selling an estimated $38.8K and leaving 30,942 shares worth $9.19M. The position accounts for 0.02% of the portfolio, ranked #445.

Nomura Holdings first reported a position in ONC in Q4 2017 and has held it in 13 quarters since. The position peaked at $12.6M in Q3 2025. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Nomura Holdings held 30,942 shares of BeOne Medicines Ltd worth $9.19M as of Q1 2026.
  • Nomura Holdings sold 120 BeOne Medicines Ltd shares in Q1 2026, an estimated $38.8K.
  • BeOne Medicines Ltd made up 0.02% of Nomura Holdings's portfolio in Q1 2026, its #445 holding.
  • Nomura Holdings first reported a position in BeOne Medicines Ltd in Q4 2017 and has held it in 13 quarters since.
  • Nomura Holdings's BeOne Medicines Ltd position peaked at $12.6M in Q3 2025.
  • 281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.